Oxidized-LDL and paraoxonase-1 as biomarkers of coronary artery disease in patients with sleep-disordered breathing

Current Medicinal Chemistry

Volumn 19, Issue 25, 2012, Pages 4359-4366

  Hackenhaar, F S ^a,b   Martinez, D ^a,c   Medeiros, T M ^a,b   Klein, C ^a,b   Alabarse, P V G ^a,b   Wainstein, M V ^c   Goncalves S C ^c   Benfato, M S ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Programa de Pós Graduação em Biologia Celular e Molecular   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Atherosclerosis; HDL; LDL; NO ; Obstructive sleep apnea; ox LDL; PON 1

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; MALE; OXIDATION; OXIDATIVE STRESS; OXYGEN SATURATION; SLEEP DISORDERED BREATHING; TRIACYLGLYCEROL BLOOD LEVEL;

ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRATES; NITRITES; SLEEP APNEA SYNDROMES;

EID: 84866712805     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712802884312     Document Type: Article

References (48)

1. Mooe, T.; Rabben, T.; Wiklund, U.; Franklin, K.A.; Eriksson, P. Sleepdisordered breathing in men with coronary artery disease. Chest, 1996, 109(3), 659-663.
2. Bradley, T.D.; Floras, J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet, 2009, 373(9657), 82-93.
3. Luthje, L.; Andreas S. Obstructive sleep apnea and coronary artery disease. Sleep Med. Rev., 2008, 12(1), 19-31.
4. Celen, Y.T.; Peker, Y. Cardiovascular consequences of sleep apnea: IICardiovascular mechanisms. Anadolu Kardiyoloji Dergisi., 2010, 10(2), 168-175.
5. Klein, C.; Martinez, D.; Hackenhaar, F.S.; Medeiros, T.M.; Marcolin, M.L.; Silveira, F.S.; Wainstein, M.V.; Goncalvez, S.C.; Benfato, M.S. Carbonyl groups: Bridging the gap between sleep disordered breathing and coronary artery disease. Free Radic. Res., 2010, 44(8), 907-912.
6. Khayat, R.; Patt, B.; Hayes, D. Obstructive sleep apnea: the new cardiovascular disease. Part I: obstructive sleep apnea and the pathogenesis of vascular disease. Heart Failure Rev., 2009, 14(3), 143-153.
7. Singh, U.; Jialal I. Oxidative stress and atherosclerosis. Pathophysiology, 2006, 13(3), 129-142.
8. Tavori, H.; Aviram, M.; Khatib, S.; Musa, R.; Nitecki, S.; Hoffman, A.; Vaya, J. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic. Biol. Med., 2009, 46(5), 607-615.
9. Levitan, I.; Volkov, S.; Subbaiah, P. Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology. Antioxid. Redox Sign., 2010, 13(1), 39-75.
10. Tan, K.C.B.; Chow, W.S.; Lam, J.C.M.; Lam, B.; Wong, W.K.; Tam, S.; Ip, M.S. HDL dysfunction in obstructive sleep apnea. Atherosclerosis, 2006, 184(2), 377-382.
11. Gozal, D.; Kheirandish-Gozal, L. Cardiovascular morbidity in obstructive sleep apnea -Oxidative stress, inflammation, and much more. Am. J. Respir. Crit. Care Med., 2008, 177(4), 369-375.
12. Jayakumari, N.; Thejaseebai, G. High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease. J. Clin. Biochem. Nutr., 2009, 45(3), 278-284.
13. Lavie, L.; Vishnevsky, A.; Lavie, P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep, 2004, 27(1), 123-128.
14. Durrington, P.N.; Mackness, B.; Mackness, M.I, Paraoxonase and atherosclerosis. Arterioscl. Throm. Vas., 2001, 21(4), 473-480.
15. Tward, A.; Xia, Y.R.; Wang, X.P.; Shi, Y.S.; Park, C.; Castellani, L.W.; Lusis, A.J.; Shih, D.M. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation, 2002, 106(4), 484-490.
16. Ng, D.S.; Chu, T.; Esposito, B.; Hui, P.; Connelly, P.W.; Gross, P.L. Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia. Cardiovasc. Pathol., 2008, 17(4), 226-232.
17. Gackowski, D.; Kruszewski, M.; Jawien, A.; Ciecierski, M.; Olinski, R. Further evidence that oxidative stress may be a risk factor responsible for the development of atherosclerosis. Free Radical Biol. Med., 2001, 31(4), 542-547.
18. Satoh, M.; Ishikawa, Y.; Takahashi, Y.; Itoh, T.; Minami, Y.; Nakamura, M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis, 2008, 198, 347-353.
19. Collins, A.R.; Gedik, C.M.; Olmedilla, B.; Southon, S.; Bellizzi, M. Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates. Faseb J., 1998, 12(13), 1397-1400.
20. Atanasiu, V.; Manolescu, B.; Stoian, I. Hepcidin -central regulator of iron metabolism. Eur. J. Haematol., 2007, 78(1), 1-10.
21. Leclerc, X.; Godefroy, O.; Lucas, C., Benhaim, J.F, . Saint Michel, T.; Leys, D.; Pruvo, J.P. Internal carotid arterial stenosis: CT angiography with volume rendering. Radiology, 1999, 210(3), 673-682.
22. Slattery, J. Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC European Carotid Surgery Trial. Lancet, 1996, 347(9015), 1591-1593.
23. Warlow, C. MRC-european-carotid-surgery-trial -interim results for symptomatic patients with severe (70-99-percent) or with mild (0-29-percent) carotid stenosis. Lancet, 1991, 337(8752), 1235-1243.
24. Zhao, Y.; Ma, Y.; Fang, Y.; Liu, L.; Wu, S.; Fu, D.; Wang, X. Association between PON1 activity and coronary heart disease risk: A meta-analysis based on 43 studies. Mol. Genet. Metab., 2012, 105(1), 141-148.
25. Bryan, N.S.; Grisham, M.B. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic. Biol. Med., 2007, 43(5), 645-657.
26. Grisham, M.B.; Johnson, G.G.; Lancaster, J.R. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol., 1996, 268, 237-246.
27. Eckerson, H.W.; Wyte, C.M.; Ladu, B.N. The human-serum paraoxonase arylesterase polymorphism. J. Lipid. Res., 1983, 35(6), 1126-1138.
28. Van Himbergen, T.M.; Roest, M.; de Graaf, J.; Jansen, E.; Hattori, H.; Kastelein, J.J.P.; Voorbij, H.A.M.; Stalenhoef, A.F.H.; van Tits, L.J.H. Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. J. Lipid. Res., 2005, 46(3), 445-451.
29. Alabarse, P.V.G.; Hackenhaar, F.S.; Medeiros, T.M.; Almeida Mendes, M.F.; Viacava, P.R.; Schueller, A.K.; Salomon, T.B.; Ehrenbrink, G.; Benfato, M.S. Oxidative stress in the brain of reproductive male rats during aging. Exp. Gerontol., 2011, 46(4), 241-248.
30. Novak, F.; Vavrova, L.; Kodydkova, J.; Hynkova, M.; Zak, A.; Novakova, O. Decreased paraoxonase activity in critically ill patients with sepsis. Clin. Exp. Med., 2010, 10(1), 21-25.
31. Searle, A.; Gomez-Rosso, L.; Merono, T.; Salomon, C.; Duran-Sandoval, D.; Giunta, G.; Grant, C.; Calvo, C.; Lamperti, L.; Brites, F.; Aguayo, C. High LDL levels are associated with increased lipoprotein-associated phospholipase A(2) activity on nitric oxide synthesis and reactive oxygen species formation in human endothelial cells. Clin. Biochem., 2011, 44(2-3), 171-177.
32. Barish, G.D.; Evans, R.M. PPARs and LXRs: atherosclerosis goes nuclear. Trends Endocrin. Met., 2004, 15(4), 158-165.
33. Kurban, S.; Mehmetoglu, I. Effects of acetylsalicylic acid on serum paraoxonase activity, Ox-LDL, coenzyme Q(10) and other oxidative stress markers in healthy volunteers. Clin. Biochem., 2010, 43(3), 287-290.
34. Lahera, V.; Goicoechea, M.; Garcia de Vinuesa, S.; Miana, M.; de las Heras, N.; Cachofeiro, V.; Luno, J. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: Beneficial effects of statins. Curr. Med. Chem., 2007, 14(2), 243-248.
35. Harangi, M.; Seres, I.; Harangi, J.; Paragh, G. Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment. Cardiovasc. Drug Ther., 2009, 23(6), 501-510.
36. Kotani, K.; Tsuzaki, K.; Sakane, N.; Komada, I.; Schulze, J.; Gugliucci, A.; Kimura, S. Reduced paraoxonase 1/arylesterase activity and its posttherapeutic increase in obstructive sleep apnea syndrome: A preliminary study. Clin. Chim. Acta, 2008, 395(1-2), 184-185.
37. Vatansever, E.; Surmen-Gur, E.; Ursavas, A.; Karadag, M. Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath., 2011, 15(3), 275-282.
38. Roche, F.; Sforza, E.; Pichot, V.; Maudoux, D.; Garcin, A.; Celle, S.; Picard-Kossovsky, M.; Gaspoz, J.M.; Barthelemy, J.C.; Grp, P.S. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med., 2009, 10(8), 882-886.
39. Kawano, Y.; Tamura, A.; Kadota, J. Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol. Metabolism, 2012, 61(2), 186-192.
40. Tamaki, S.; Yamauchi, M.; Fukuoka, A.; Makinodan, K.; Koyama, N.; Tomoda, K.; Yoshikawa, M.; Kimura, H. Nocturnal hypoxic stress activates invasive ability of monocytes in patients with obstructive sleep apnoea syndrome. Respirol., 2009, 14(5), 689-694.
41. Drager, L.F.; Bortolotto, L.A.; Lorenzi, M.C.; Figueiredo, A.C.; Krieger, E.M.; Lorenzi, G. Early signs of atherosclerosis in obstructive sleep apnea. Am. J. Respir. Crit. Care Med., 2005, 172(5), 613-618.
42. Szaboova, E.; Tomori, Z.; Donic, V.; Petrovicova, J.; Szabo, P. Sleep apnoea inducing hypoxemia is associated with early signs of carotid atherosclerosis in males. Respir. Physiol. Neurobiol., 2007, 155(2), 121-127.
43. Jelic, S.; Padeletti, M.; Kawut, S.M.; Higgins, C.; Canfield, S.M.; Onat, D.; Colombo, P.C.; Basner, R.C.; Factor, P.; LeJemtel, T.H. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation, 2008, 117(17), 2270-2278.
44. Peng, Z.Y.; Zhao, S.P.; He, B.M.; Peng, D.Q.; Hu, M. Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway. Mol. Cell. Biochem., 2011, 351(1-2), 243-249.
45. Bisoendial, R.J.; Hovingh, G.K.; Levels, J.H.M.; Lerch, P.G.; Andresen, I.; Hayden, M.R.; Kastelein, J.J.P.; Stroes, E.S.G. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation, 2003, 107(23), 2944-2948.
46. Woodman, R.J.; Playford, D.A.; Watts, G.F. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in type 2 diabetes: Associations with blood pressure and HDL cholesterol. Diabetes Res.Clin. Pr., 2006, 71(1), 59-67.
47. Yamauchi, M.; Nakano, H.; Maekawa, J.; Okamoto, Y.; Ohnishi, Y.; Suzuki, T.; Kimura, H. Oxidative stress in obstructive sleep apnea. Chest, 2005, 127(5), 1674-1679.
48. Fabian, E.; Bogner, M.; Elmadfa, I. Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors. Eur. J. Clin. Invest., 2012, 42(1), 42-48.